Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 643525, 9 pages
http://dx.doi.org/10.1155/2014/643525
Research Article

Effect of the Toll-Like Receptor 4 Antagonist Eritoran on Retinochoroidal Inflammatory Damage in a Rat Model of Endotoxin-Induced Inflammation

1Department of Ophthalmology, Recep Tayyip Erdogan University Medical School, 53020 Rize, Turkey
2Department of Ophthalmology, Sorgun State Hospital, 66700 Yozgat, Turkey
3Department of Ophthalmology, Duzce State Hospital, 81100 Duzce, Turkey
4Department of General Surgery, Gazi University Medical School, 06560 Ankara, Turkey
5Department of Medical Biochemistry, Gazi University Medical School, 06560 Ankara, Turkey
6Department of Pathology, Dışkapı Training and Research Hospital, 06330 Ankara, Turkey
7Department of Medical Pharmacology, Gazi University Medical School, 06560 Ankara, Turkey
8Department of Ophthalmology, Gazi University Medical School, 06560 Ankara, Turkey

Received 23 March 2014; Revised 29 May 2014; Accepted 29 May 2014; Published 17 June 2014

Academic Editor: Andrzej Grzybowski

Copyright © 2014 Feyzahan Ekici et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Krawczyk-Michalak, A. Glapiński, and E. Brzezińska-Błaszczyk, “Toll-like receptors and their role in regulation of the inflammatory response in sepsis,” Anestezjologia Intensywna Terapia, vol. 40, no. 4, pp. 253–259, 2008. View at Google Scholar
  2. W. J. Wiersinga and T. van der Poll, “The role of toll-like receptors in sepsis,” in Yearbook of Intensive Care and Emergency Medicine, J. L. Vincent, Ed., part 1, pp. 3–13, Springer, Heidelberg, Germany, 2006. View at Google Scholar
  3. X. Wittebole, D. Castanares-Zapatero, and P. F. Laterre, “Toll-like receptor 4 modulation as a strategy to treat sepsis,” Mediators of Inflammation, vol. 2010, Article ID 568396, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Marnett, “Lipid peroxidation—DNA damage by malondialdehyde,” Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 424, no. 1-2, pp. 83–95, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. W. A. Pryor and J. P. Stanley, “A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation,” Journal of Organic Chemistry, vol. 40, no. 24, pp. 3615–3617, 1975. View at Google Scholar · View at Scopus
  6. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. I. Song, T. A. Abraham, Y. Park et al., “The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells,” Investigative Ophthalmology and Visual Science, vol. 42, no. 12, pp. 2867–2877, 2001. View at Google Scholar · View at Scopus
  8. N. Kumagai, K. Fukuda, Y. Fujitsu, Y. Lu, N. Chikamoto, and T. Nishida, “Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts,” Investigative Ophthalmology and Visual Science, vol. 46, no. 1, pp. 114–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. B. E. Brito, D. O. Zamora, R. A. Bonnah, Y. Pan, S. R. Planck, and J. T. Rosenbaum, “Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells,” Experimental Eye Research, vol. 79, no. 2, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Chang, P. McCluskey, and D. Wakefield, “Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea,” Investigative Ophthalmology and Visual Science, vol. 45, no. 6, pp. 1871–1878, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. L. Kindzelskii, V. M. Elner, S. G. Elner, D. Yang, B. A. Hughes, and H. R. Petty, “Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments,” Journal of General Physiology, vol. 124, no. 2, pp. 139–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. J. T. Rosenbaum, “Endotoxin-induced uveitis,” in Animal Models of Ocular Diseases, K. F. Tabarra and R. M. Cello, Eds., pp. 247–253, Thomas, Springfield, Ill, USA, 1984. View at Google Scholar
  13. J. T. Rosenbaum, H. O. McDevitt, R. B. Guss, and P. R. Egbert, “Endotoxin-induced uveitis in rats as a model for human disease,” Nature, vol. 286, no. 5773, pp. 611–613, 1980. View at Google Scholar · View at Scopus
  14. P. Yang, A. F. de Vos, and A. Kijlstra, “Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide,” Investigative Ophthalmology and Visual Science, vol. 37, no. 1, pp. 77–85, 1996. View at Google Scholar · View at Scopus
  15. J. M. Ruiz-Moreno, B. Thillaye, and Y. de Kozak, “Retino-choroidal changes in endotoxin-induced uveitis in the rat,” Ophthalmic Research, vol. 24, no. 3, pp. 162–168, 1992. View at Google Scholar · View at Scopus
  16. P. Bhattacherjee, R. N. Williams, and K. E. Eakins, “An evaluation of ocular inflammation following the injection of bacterial endotoxin into the rat foot pad,” Investigative Ophthalmology and Visual Science, vol. 24, no. 2, pp. 196–202, 1983. View at Google Scholar · View at Scopus
  17. K. Koizumi, V. Poulaki, S. Doehmen et al., “Contribution of TNF-α to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo,” Investigative Ophthalmology and Visual Science, vol. 44, no. 5, pp. 2184–2191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Kalsow and A. E. Dwyer, “Retinal immunopathology in horses with uveitis,” Ocular Immunology and Inflammation, vol. 6, no. 4, pp. 239–251, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. H. M. Kim, B. S. Park, J.-I. Kim et al., “Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran,” Cell, vol. 130, no. 5, pp. 906–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. P. Rossignol and M. Lynn, “Antagonism of in vivo and ex vivo response to endotoxin by E5564, an synthetic lipid A analogue,” Journal of Endotoxin Research, vol. 8, no. 6, pp. 483–488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Mullarkey, J. R. Rose, J. Bristol et al., “Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist,” Journal of Pharmacology and Experimental Therapeutics, vol. 304, no. 3, pp. 1093–1102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Czeslick, A. Struppert, A. Simm, and A. Sablotzki, “E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes,” Inflammation Research, vol. 55, no. 11, pp. 511–515, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Chen, X.-F. Hu, L. Zhao, S. Li, and H. Lu, “Toll-like receptor 4 expression in macrophages in endotoxin-induced uveitis in Wistar rats,” Chinese Journal of Ophthalmology, vol. 46, no. 4, pp. 355–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Li, H. Lu, X. Hu, W. Chen, Y. Xu, and J. Wang, “Expression of TLR4-MyD88 and NF-B in the iris during endotoxin-induced uveitis,” Mediators of Inflammation, vol. 2010, Article ID 748218, 7 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. S. T. Qureshi, L. Larivière, G. Leveque et al., “Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4),” Journal of Experimental Medicine, vol. 189, no. 4, pp. 615–625, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Z. Movat, M. I. Cybulsky, I. G. Colditz, M. K. Chan, and C. A. Dinarello, “Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils,” Federation Proceedings, vol. 46, no. 1, pp. 97–104, 1987. View at Google Scholar · View at Scopus
  27. T. van der Poll and S. F. Lowry, “Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?” Shock, vol. 3, no. 1, pp. 1–12, 1995. View at Google Scholar · View at Scopus
  28. C. Evereklioglu, H. Er, Y. Türköz, and M. Cekmen, “Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease,” Mediators of Inflammation, vol. 11, no. 2, pp. 87–93, 2002. View at Publisher · View at Google Scholar
  29. A. F. de Vos, V. N. A. Klaren, and A. Kijlstra, “Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat,” Investigative Ophthalmology and Visual Science, vol. 35, no. 11, pp. 3873–3883, 1994. View at Google Scholar · View at Scopus
  30. U. Pleyer, F. Mackensen, S. Winterhalter, and N. Stübiger, “Anti-TNF-α treatment for uveitis. Analysis of the current situation,” Ophthalmologe, vol. 108, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Neri, M. Zucchi, P. Allegri, M. Lettieri, C. Mariotti, and A. Giovannini, “Adalimumab (Humira): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology,” International Ophthalmology, vol. 31, no. 2, pp. 165–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Goto, G.-S. Wu, F. Chen, M. Kristeva, A. Sevanian, and N. A. Rao, “Lipid peroxidation in experimental uveitis: sequential studies,” Current Eye Research, vol. 11, no. 6, pp. 489–499, 1992. View at Google Scholar · View at Scopus
  33. N. A. Rao, “Role of oxygen free radicals in retinal damage associated with experimental uveitis,” Transactions of the American Ophthalmological Society, vol. 88, pp. 797–850, 1990. View at Google Scholar · View at Scopus
  34. G.-S. Wu, J. Walker, and N. A. Rao, “Effect of deferoxamine on retinal lipid peroxidation in experimental uveitis,” Investigative Ophthalmology and Visual Science, vol. 34, no. 11, pp. 3084–3089, 1993. View at Google Scholar · View at Scopus
  35. F. Bosch-Morell, J. Romá, N. Marín et al., “Role of oxygen and nitrogen species in experimental uveitis: anti-inflammatory activity of the synthetic antioxidant ebselen,” Free Radical Biology and Medicine, vol. 33, no. 5, pp. 669–675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. F. Liu and A. B. Malik, “NF-kappa B activation as a pathological mechanism of septic shock and inflammation,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 290, no. 4, pp. L622–L645, 2006. View at Publisher · View at Google Scholar
  37. H. Böhrer, F. Qiu, T. Zimmermann et al., “Role of NFκB in the mortality of sepsis,” The Journal of Clinical Investigation, vol. 100, no. 5, pp. 972–985, 1997. View at Google Scholar
  38. F. Arnalich, E. Garcia-Palomero, J. López et al., “Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis,” Infection and Immunity, vol. 68, no. 4, pp. 1942–1945, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Kubota, T. Kurihara, H. Mochimar et al., “Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-κB activation,” Investigative Ophthalmology and Visual Science, vol. 50, no. 7, pp. 3512–3519, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Kitamei, K. Iwabuchi, K. Namba et al., “Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate,” Journal of Leukocyte Biology, vol. 79, no. 6, pp. 1193–1201, 2006. View at Publisher · View at Google Scholar · View at Scopus